title: Is testing for glucose-6-phosphate dehydrogenase deficiency before starting sulfa useful in HIV-infected male patients originating from sub-Saharan Africa?
authors.forename: Pierre O
authors.initials: PO
authors.lastname: Sellier
authors.forename: Nathalie
authors.initials: N
authors.lastname: Mario
authors.forename: Agathe
authors.initials: A
authors.lastname: Rami
authors.forename: Annalisa
authors.initials: A
authors.lastname: Andreoli
authors.forename: Beda M
authors.initials: BM
authors.lastname: Choho
authors.forename: Guy
authors.initials: G
authors.lastname: Simoneau
authors.forename: Jean-Dominique
authors.initials: JD
authors.lastname: Magnier
authors.forename: John
authors.initials: J
authors.lastname: Evans
authors.forename: Philippe
authors.initials: P
authors.lastname: Chappuis
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bergmann
mesh_terms: D000328:Adult; D017954:Africa South of the Sahara; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D018890:Chemoprevention / Q000379:methods*; D054242:Emigrants and Immigrants; D005260:Female; D005602:France; D005820:Genetic Testing / Q000706:statistics & numerical data*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000175:diagnosis*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*
chemical_list: D000890:Anti-Infective Agents